Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed the stock exchanges that its board of directors will meet on September 25, 2025 to consider issuing equity shares and/or warrants through a preferential allotment route, in line with SEBI's ICDR Regulations and the Companies Act, 2013. The proposal is subject to regulatory and statutory approvals. As a result, the company's trading window has been closed from the date of this intimation until 48 hours after the board meeting concludes.
This is a pre-announcement signaling potential dilution for existing shareholders if the preferential allotment goes through. Investors should watch for details on the issue price, size, and identity of allottees once the board approves the proposal on September 25.